Clinical Trials Browser

Completed × Neuroma, Acoustic × 1 year × Clear all

Neuroma, Acoustic

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT07305285 2025-12-26

Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma

Phase NA Completed

160 enrolled

CNS

Facial Paralysis, Neuroma, Acoustic

NCT04057976 2025-09-12

Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas

Phase NA Completed

38 enrolled

CNS

Neuroma, Acoustic

NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Phase 2 Completed

50 enrolled

CNS

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT02249572 2025-04-02

V-REX

Phase NA Completed

100 enrolled

CNS

Neuroma, Acoustic

Clinical Trials

Vestibular Schwannoma Organoids

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma

Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

V-REX